Generic placeholder image

Protein & Peptide Letters

Editor-in-Chief

ISSN (Print): 0929-8665
ISSN (Online): 1875-5305

Human Retinoblastoma Binding Protein 9, a Serine Hydrolase Implicated in Pancreatic Cancers

Author(s): Sergey M. Vorobiev, Yuanpeng Janet Huang, Jayaraman Seetharaman, Rong Xiao, Thomas B. Acton, Gaetano T. Montelione and Liang Tong

Volume 19, Issue 2, 2012

Page: [194 - 197] Pages: 4

DOI: 10.2174/092986612799080356

Price: $65

Abstract

Human retinoblastoma binding protein 9 (RBBP9) is an interacting partner of the retinoblastoma susceptibility protein (Rb). RBBP9 is a tumor-associated protein required for pancreatic neoplasia, affects cell cycle control, and is involved in the TGF-β signalling pathway. Sequence analysis suggests that RBBP9 belongs to the α/β hydrolase superfamily of enzymes. The serine hydrolase activity of RBBP9 is required for development of pancreatic carcinomas in part by inhibiting TGF-β antiproliferative signaling through suppressing Smad2/3 phosphorylation. The crystal structure of human RBBP9 confirms the α/β hydrolase fold, with a six-stranded parallel β-sheet flanked by α helixes. The structure of RBBP9 resembles that of the YdeN protein from Bacillus subtilis, which is suggested to have carboxylesterase activity. RBBP9 contains a Ser75-His165-Asp138 catalytic triad, situated in a prominent pocket on the surface of the protein. The side chains of the LxCxE sequence motif that is important for interaction with Rb is mostly buried in the structure. Structure- function studies of RBBP9 suggest possible routes for novel cancer drug discovery programs.

Keywords: α/β hydrolase, pancreatic cancer, protein structure, structural genomics, RBBP9, antiproliferative, Smad2/3 phosphorylation, Bacillus subtilis, Ser75, emetine, E-cadherin


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy